10:34 AM EST - Oncolytics Biotech Inc. : Today reported on highlights and financial results for Q4 and year-end 2024. The net loss for the fourth quarter of 2024 was $8.0 million, compared to a net loss of $3.9 million for the fourth quarter of 2023. The basic and diluted loss per share was $0.10 in the fourth quarter of 2024, compared to a basic and diluted loss per share of $0.05 in the fourth quarter of 2023.
Oncolytics Biotech Inc.
shares T.ONC are trading down $0.10 at $0.98.
